Rajasekharan Somasundaram

Rajasekharan Somasundaram

UNVERIFIED PROFILE

Are you Rajasekharan Somasundaram?   Register this Author

Register author
Rajasekharan Somasundaram

Rajasekharan Somasundaram

Publications by authors named "Rajasekharan Somasundaram"

Are you Rajasekharan Somasundaram?   Register this Author

47Publications

902Reads

25Profile Views

The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.

Target Oncol 2017 04;12(2):139-152

Center for Translational Cancer Research, Helen F Graham Cancer Center and Research Institute, Christiana Care Health Services, Inc., 4701 Ogletown Stanton Rd Suite 4300, Newark, DE, 19713, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11523-017-0481-x
Publisher Site
http://dx.doi.org/10.1007/s11523-017-0481-xDOI Listing
April 2017

Nivolumab in combination with ipilimumab for the treatment of melanoma.

Expert Rev Anticancer Ther 2015 ;15(10):1135-41

a The Wistar Institute, 3601 Spruce St, Philadelphia, PA19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1093418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669949PMC
May 2016

The role of tumor microenvironment in melanoma therapy resistance.

Melanoma Manag 2016 Mar 12;3(1):23-32. Epub 2016 Feb 12.

Division of Immunology, Allergy & Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, 1090 Wien, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/mmt.15.37DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094607PMC
March 2016

Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma.

Melanoma Res 2016 Feb;26(1):1-11

aHarrison Department of Surgical Research, Perelman School of Medicine, University of Pennsylvania bWistar Institute, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000203DOI Listing
February 2016

Heterogeneity in Melanoma.

Cancer Treat Res 2016 ;167:1-15

Molecular and Cellular Oncogenesis Program, Melanoma Research Center, The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-22539-5_1DOI Listing
January 2016

Indomethacin to the rescue of TRAIL-resistant melanomas.

J Invest Dermatol 2014 May;134(5):1198-1199

Molecular and Cellular Oncogenesis Program, Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X153678
Publisher Site
http://dx.doi.org/10.1038/jid.2014.1DOI Listing
May 2014

Combination therapy of immunocytokines with ipilimumab: a cure for melanoma?

J Invest Dermatol 2013 Mar;133(3):595-596

Tumor Microenvironment and Metastasis Program, Melanoma Research Center, The Wistar Institute, Philadelphia, Pennsylvania, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2012.433DOI Listing
March 2013

Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations.

Adv Pharmacol 2012 ;65:335-59

Molecular and Cellular Oncogenesis Program, Melanoma Research Center, The Wistar Institute, Philadelphia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-397927-8.00011-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677516PMC
February 2013

Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches.

Oncoimmunology 2012 Nov;1(8):1454-1456

Division of Immunology, Allergy and Infectious Diseases; Department of Dermatology; Vienna, Austria.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/onci.21357
Publisher Site
http://dx.doi.org/10.4161/onci.21357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518536PMC
November 2012

Melanoma exosomes: messengers of metastasis.

Nat Med 2012 Jun 6;18(6):853-4. Epub 2012 Jun 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.2775DOI Listing
June 2012

Will engineered T cells expressing CD20 scFv eradicate Melanoma?

Mol Ther 2011 Apr;19(4):638-40

Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2011.46DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070110PMC
April 2011

Chemokines and the microenvironment in neuroectodermal tumor-host interaction.

Semin Cancer Biol 2009 Apr 13;19(2):92-6. Epub 2008 Nov 13.

The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S1044579X0800090
Publisher Site
http://dx.doi.org/10.1016/j.semcancer.2008.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806055PMC
April 2009

Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.

Cancer Biol Ther 2006 Oct 4;5(10):1304-12. Epub 2006 Oct 4.

The Wistar Institute, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, and Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.5.10.3153DOI Listing
October 2006

Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients.

Cancer Immunol Immunother 2006 May 21;55(5):528-37. Epub 2005 Jul 21.

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0026-5DOI Listing
May 2006

CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma.

J Transl Med 2005 Nov 10;3:41. Epub 2005 Nov 10.

The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://translational-medicine.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/1479-5876-3-41DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308870PMC
November 2005

Colon cancer antigen and anti-idiotype vaccines.

Cancer Chemother Biol Response Modif 2003 ;21:287-98

The Wistar Institute, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
September 2004